STUDY DESIGN:
Cross-sectional analysis.
SETTING & PARTICIPANTS:
30,528 participants in the US National Health and Nutrition Examination Survey conducted in 1988 Survey conducted in -1994 Survey conducted in and 1999 Survey conducted in -2006 for hyperparathyroidism).
PREDICTORS:
Classification system that uses both eGFR and proteinuria (alternative) and a system that primarily uses eGFR (NKF-KDOQI [National Kidney Foundation's Kidney Disease Outcomes Quality Initiative]).
OUTCOMES:
Prevalence of anemia, acidosis, hyperphosphatemia, hypoalbuminemia, hyperparathyroidism, and hypertension.
MEASUREMENTS:
GFR estimated from the CKD Epidemiology Collaboration (CKD-EPI) equation and proteinuria assessed using urine albumincreatinine ratio.
RESULTS:
Prevalences of hypoalbuminemia, hypertension, and hyperparathyroidism increased with more severe CKD using the NKF-KDOQI system. For example, the prevalence of hyperparathyroidism was 9.1%, 11.1%, 28.2%, and 72.5% for stages 1, 2, 3 and 4, respectively. Similarly, prevalences of anemia, acidosis, and Page 1 of 2
Comparison of concurrent complications of CKD by 2 risk categorization systems.
Published on UAB School of Public Health (http://www.soph.uab.edu) hyperphosphatemia increased progressively from stage 2 through 4. With the alternative system, prevalences of anemia, hyperphosphatemia, hypertension, and hyperparathyroidism were lower in stage 3 than in stage 2. For example, the prevalence of hyperparathyroidism was 13.5%, 40.3%, 22.2%, and 63.4% for stages 1, 2, 3 and 4, respectively. Applying the alternative system, participants without each complication were more likely to be reclassified appropriately to lower stages (eg, overall net reclassification index of -6.5% for hyperparathyroidism). However, participants with complications (except for hypoalbuminemia) were more likely to be reclassified inappropriately to lower stages.
